10 enregistrements totalisant 12,799,991.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
| Instituts de recherche en santé du Canada | $12,799,991 | 10 enregistrements |
The Centre for the Commercialization of Antibodies and Biologics (CCAB)
Specific inhibitors of ubiquitin ligases and deubiquitinases
Design and Application of Combinatorial Libraries of Synthetic Antibodies and Alternative Scaffolds
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to: • Contribute to the global response to the 2019-nCoV outbreak; • Enhance local, national and/or internat...
Inhibitors of viral pathogenic deubiquitinases
The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
Engineering therapeutics for the treatment of anemia in oncology patients
Highly specific therapeutic-grade anti-FGFR1 antibodies with anti-proliferative effects
Co-targeting sensitizing integrin receptors and oncogenic growth factor receptors in lung cancer with bispecific antibodies
The objectives of Stream 1 are: •Accelerate rapid research on SARS-CoV-2 variants in Canada to contribute to the national and global efforts to address SARS-CoV-2 variants; and •Generate timely evid...